Patents Assigned to Phage Biotechnology
  • Patent number: 7435804
    Abstract: A bacterial high-expression system which is applicable for simultaneous screening of large numbers of recombinant clones from combinatorial antibody libraries is disclosed. The method pertains to screening of single chain antibodies from libraries expressed in the periplasm of E. coli by secretion. By this approach, approximately 104 clones can be screened in a single round. After screening, the clones, which express the recombinant antibodies to the desired antigen, can be directly used for production of large quantities of antibodies from microorganism culture. The system is especially attractive for fast screening of antibody libraries from a hybridoma source. A refolding method for the large-scale production of biologically active scFv-6 his proteins from bacterial inclusion bodies is also disclosed.
    Type: Grant
    Filed: October 19, 2004
    Date of Patent: October 14, 2008
    Assignee: Phage Biotechnology, Inc.
    Inventors: Vitaliy A. Kordyum, Oleg Okunev, Pavlo Gilchuk, Olena Deryabina, Dmitro Irodov
  • Publication number: 20080193992
    Abstract: This invention relates to the use of microorganisms for the generation of ethanol from lignocellulosic waste materials. Yeast strains of the genus Kluyveromyces which have the capability to ferment cellulose, hexose sugars to ethanol are provided. Also provided are methods for converting cellulose, hexoses, or mixed hydrolysates of hexoses to ethanol by fermentation with Kluyveromyces strains. The invention also provides methods to isolate yeast strains which metabolize cellulose, pentoses, or hemicelluloses from waste materials.
    Type: Application
    Filed: February 1, 2008
    Publication date: August 14, 2008
    Applicant: Phage Biotechnology
    Inventor: Robert Paul Levine
  • Patent number: 7344876
    Abstract: This invention relates to the use of microorganisms for the generation of ethanol from lignocellulosic waste materials. Yeast strains of the genus Kluyveromyces which have the capability to ferment cellulose, hexose sugars to ethanol are provided. Also provided are methods for converting cellulose, hexoses, or mixed hydrolysates of hexoses to ethanol by fermentation with Kluyveromyces strains. The invention also provides methods to isolate yeast strains which metabolize cellulose, pentoses, or hemicelluloses from waste materials.
    Type: Grant
    Filed: January 16, 2004
    Date of Patent: March 18, 2008
    Assignee: Phage Biotechnology, Inc.
    Inventor: Robert Paul Levine
  • Patent number: 6794162
    Abstract: This invention relates to a method for enhancing the production of biologically active proteins and peptides in bacterial cells by infecting bacterial cells of the producer strain, which contain a plasmid with one or more targeted genes, with bacteriophage &lgr; with or without the targeted gene(s). The phage increases synthesis of the targeted protein and induces lysis of the producer strain cells. Super-production is achieved by cultivating the producer strain cells under culture conditions that delay lytic development of the phage. The biologically active proteins and peptides subsequently accumulate in a soluble form in the culture medium as the cells of the producer strain are lysed by the phage.
    Type: Grant
    Filed: May 17, 2001
    Date of Patent: September 21, 2004
    Assignee: Phage Biotechnology Corporation
    Inventors: Vitaliy A. Kordyum, Svitlana I. Chernykh, Iryna Yu Slavchenko, Oleksandr F. Vozlanov
  • Patent number: 6773899
    Abstract: This invention relates to a method for enhancing the production of biologically active proteins and peptides in bacterial cells by infecting bacterial cells of the producer strain, which contain a plasmid with one or more targeted genes, with bacteriophage &lgr; with or without the targeted gene(s). The targeted genes encoding the biologically active proteins are under the control of a T7 polymerase promoter and the bacteria also are capable of expressing the gene for T7 RNA polymerase. The phage increases synthesis of the targeted protein and induces lysis of the producer strain cells. Super-production is achieved by the combination of the high level of expression achieved from the T7 polymerase promoter and by cultivating the producer strain cells under culture conditions that delay lytic development of the phage. The biologically active proteins and peptides subsequently accumulate in a soluble form in the culture medium as the cells of the producer strain are lysed by the phage.
    Type: Grant
    Filed: August 15, 2001
    Date of Patent: August 10, 2004
    Assignee: Phage Biotechnology Corporation
    Inventors: Vitaliy A. Kordyum, Iryna Yu. Slavchenko, Svitlana I. Chernykh, Oleksandr F. Vozianov
  • Patent number: 6642026
    Abstract: The gene of human acidic fibroblast growth factor 155 (haFGF 155) has been obtained by chemical synthesis. The nucleotide sequence of haFGF 155 gene has been deduced on the basis of haFGF 155 amino acid sequence as described in the literature. The amino acid sequence of the synthesized haFGF 155 does not differ from those described in the literature. The nucleotide sequence of haFGF gene differs from those described previously. For chemical synthesis of haFGF 155 gene, codons were used which are the ones most often used by E. coli in highly expressed E. coli proteins. A plasmid with haPGF 155 (phaFGF 155) gene was obtained and was used to transform E. coli. Production of haFGF 154 protein was achieved by cultivation of the producer strain under conditions which slow down the lytic development of lambda phage. The haFGF 154 protein accumulated in culture medium in a soluble condition as a result of the producer strain cells lysis by the lambda phage.
    Type: Grant
    Filed: August 15, 2001
    Date of Patent: November 4, 2003
    Assignee: Phage Biotechnology Corporation
    Inventors: Thomas J. Stegmann, Vitaliy A. Kordyum, Iryna Yu. Slavchenko, Svitlana I. Chernykh, Oleksandr F. Vozianov
  • Patent number: 6268178
    Abstract: This invention relates to a method for enhancing the production of biologically active proteins and peptides in bacterial cells by infecting bacterial cells of the producer strain, which contain a plasmid with one or more targeted genes, with bacteriophage &lgr; with or without the targeted gene(s). The phage increases synthesis of the targeted protein and induces lysis of the producer strain cells. Super-production is achieved by cultivating the producer strain cells under culture conditions that delay lytic development of the phage. The biologically active proteins and peptides subsequently accumulate in a soluble form in the culture medium as the cells of the producer strain are lysed by the phage.
    Type: Grant
    Filed: May 25, 1999
    Date of Patent: July 31, 2001
    Assignee: Phage Biotechnology Corp.
    Inventors: Vitaliy A. Kordyum, Svetlana I. Chernykh, Irina Y. Slavchenko, Oleksandr F. Vozianov